ProUroCare Medical Inc. announced that life sciences veteran Doris Engibous has entered into a contract to act as its interim Chief Operating Officer. Ms. Engibous' primary assignment during this interim period is to direct activities leading to a 510(k) submission for a reusable probe for the ProUroScan system, the placements of systems at key opinion leader sites, and the production of systems in advance of market launch.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2014 | ProUroCare Medical Inc. Announces Resignation of Robert Rudelius from the Board of Directors | CI |
2013 | ProUroCare Medical Inc. announced that it expects to receive $0.50 million in funding. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.86K | |
-0.97% | 15.37B | |
-36.20% | 2.92B | |
-12.03% | 2.48B | |
-12.41% | 1.45B | |
-.--% | 1.12B | |
+65.31% | 609M | |
+89.23% | 499M | |
+17.52% | 249M | |
-2.35% | 225M |
- Stock Market
- Equities
- PUMD Stock
- News ProUroCare Medical Inc.
- ProUroCare Medical Inc. Appoints Doris Engibous as Interim Chief Operating Officer